These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31960032)

  • 21. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
    Jiang H; Su H; Zhang C; Liu X; Li R; Zhong N; Zhao M
    Eur Neuropsychopharmacol; 2020 Jun; 35():136-137. PubMed ID: 32307223
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.
    Rawson RA; Rieckmann T; Cousins S; McCann M; Pearce R
    Prev Med; 2019 Nov; 128():105785. PubMed ID: 31362002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and emerging options to combat the opioid epidemic.
    Kominek C
    Am J Manag Care; 2018 May; 24(10 Suppl):S207-S214. PubMed ID: 29851450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to treatment for opioid use disorders: Medical student preparation.
    McCance-Katz EF; George P; Scott NA; Dollase R; Tunkel AR; McDonald J
    Am J Addict; 2017 Jun; 26(4):316-318. PubMed ID: 28394437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
    Pena E; Ahmed S
    Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
    [No Abstract]   [Full Text] [Related]  

  • 26. Medication-Assisted Treatment for Opioid-Use Disorder.
    Oesterle TS; Thusius NJ; Rummans TA; Gold MS
    Mayo Clin Proc; 2019 Oct; 94(10):2072-2086. PubMed ID: 31543255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
    Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
    Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
    Nayak SM; Huhn AS; Bergeria CL; Strain EC; Dunn KE
    Drug Alcohol Depend; 2021 Apr; 221():108649. PubMed ID: 33640679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison table: some drugs for maintenance treatment of opioid use disorder.
    Med Lett Drugs Ther; 2017 May; 59(1521):e96-e97. PubMed ID: 28609422
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular Genetics and New Medication Strategies for Opioid Addiction.
    Hurd YL; O'Brien CP
    Am J Psychiatry; 2018 Oct; 175(10):935-942. PubMed ID: 30068261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs for opioid Use disorder.
    Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420
    [No Abstract]   [Full Text] [Related]  

  • 32. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enough.
    Stahl SM
    CNS Spectr; 2018 Apr; 23(2):113-116. PubMed ID: 29676241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
    Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
    [No Abstract]   [Full Text] [Related]  

  • 35. Staring down the opioid epidemic.
    Unger JR
    J Fam Pract; 2017 Jan; 66(1):8. PubMed ID: 28188310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.
    Miles J; Howell J; Sheridan D; Braucht G; Mericle A
    Am J Drug Alcohol Abuse; 2020 May; 46(3):266-272. PubMed ID: 32091262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving care for hospitalized, opioid-dependent patients: a promising start.
    Kushel M
    JAMA Intern Med; 2014 Aug; 174(8):1377-8. PubMed ID: 24978013
    [No Abstract]   [Full Text] [Related]  

  • 38. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
    Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
    Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public Safety is Public Health; Public Health is Public Safety: Adult Correction's Response to the Opioid Epidemic in North Carolina.
    Prater JH; Brown S
    N C Med J; 2018; 79(3):189-190. PubMed ID: 29735628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.